These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7411554)

  • 21. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
    Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin receptor binding affinities of tryptamine analogues.
    Glennon RA; Gessner PK
    J Med Chem; 1979 Apr; 22(4):428-32. PubMed ID: 430481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities.
    Glennon RA; Young R; Rosecrans JA; Kallman MJ
    Psychopharmacology (Berl); 1980; 68(2):155-8. PubMed ID: 6776558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and (S)-2-aminobutane.
    Oberlender R; Pfaff RC; Johnson MP; Huang XM; Nichols DE
    J Med Chem; 1992 Jan; 35(2):203-11. PubMed ID: 1732537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral properties of psychoactive phenylisopropylamines in rats.
    Glennon RA; Rosecrans JA; Young R
    Eur J Pharmacol; 1981 Dec; 76(4):353-60. PubMed ID: 7327208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.
    Gerasimov M; Marona-Lewicka D; Kurrasch-Orbaugh DM; Qandil AM; Nichols DE
    J Med Chem; 1999 Oct; 42(20):4257-63. PubMed ID: 10514296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).
    Glennon RA; McKenney JD; Young R
    Life Sci; 1984 Oct; 35(14):1475-80. PubMed ID: 6482668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
    Young R; Glennon RA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):594-601. PubMed ID: 8632326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin receptor affinity of cathinone and related analogues.
    Glennon RA; Liebowitz SM
    J Med Chem; 1982 Apr; 25(4):393-7. PubMed ID: 7069716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Titeler M; Seggel MR; Lyon RA
    J Med Chem; 1987 May; 30(5):930-2. PubMed ID: 3572981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines.
    Oberlender R; Ramachandran PV; Johnson MP; Huang X; Nichols DE
    J Med Chem; 1995 Sep; 38(18):3593-601. PubMed ID: 7658446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A.
    Peet MM; Baker LE
    Behav Pharmacol; 2011 Sep; 22(5-6):450-7. PubMed ID: 21814135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
    Glennon RA; Titeler M; McKenney JD
    Life Sci; 1984 Dec; 35(25):2505-11. PubMed ID: 6513725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Glennon RA
    Life Sci; 1986 Sep; 39(9):825-30. PubMed ID: 2943960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
    J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on several 7-substituted N,N-dimethyltryptamines.
    Glennon RA; Schubert E; Jacyno JM; Rosecrans JA
    J Med Chem; 1980 Nov; 23(11):1222-6. PubMed ID: 6779006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.